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Background: Prior authorization, audit and feedback, and pay for performance are 
the three core “active” strategies of antimicrobial stewardship program (ASP), yet little 
is known about the individual or combined benefits of such programs, particularly in a 
pediatric setting.
Objectives: The aim of this study was to compare these core ASP strategies and deter-
mine the incremental effect of financially punished audit and feedback.
Methods: During the journey to the Joint Commission International accreditation, 
a tertiary pediatric medical center performed two different hospital-wide steward-
ship interventions in succession. The first stage without formalized ASPs served as 
pre-intervention period, January 2011 to April 2011. The ASP used prior authorization 
alone during the first-intervention period, May 2011 to September 2011. In October 
2011, financially punished audit and feedback was introduced, marking the start of 
the second-intervention period, October 2011 to November 2012. We compared the 
differences of the change in monthly average use of antibiotics and expenditure on 
 antibiotics before and after the ASP changes by using interrupted time series via dynamic 
regression. The main end points included the proportions of antibiotic prescriptions and 
expenditure on antibacterial relative to all medications.
Abbreviations: GWCMC, Guangzhou Women and Children’s Medical Center.
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inTrODUcTiOn
According to most standards, the increasing availability of life-
saving antibiotics in the developing world is a good thing. But, 
their widespread availability and inappropriate use have led to the 
development of multidrug-resistant (MDR) bacterial infections 
(1, 2). During the past two decades, a dramatic increase in the 
incidence of nosocomial infections has occurred in children (3). 
The overuse and misuse of antimicrobial agents are considered 
key points fueling this situation (4, 5). For instance, antibiotics 
are prescribed during more than 50% of hospitalizations of 
children, often unnecessarily (6), which could be even worse in 
poorer countries than in richer ones, owing in part to a lack of 
regulation (1).
Antimicrobial stewardship programs (ASPs) are multidis-
ciplinary, hospital-based interventions designed to ensure the 
appropriate prescription of antibiotics. Despite limited evidence, 
studies on ASPs have identified several potential strategies, 
including three core “active” methods: formulary restriction with 
prior authorization, prospective audit with feedback to prescrib-
ers, and pay for performance (7). Prior authorization permits the 
use of select agents after approval from the ASP team, whereas 
prospective audit and feedback utilizes post-prescriptive reviews 
conducted by the ASP to recommend changes in the antibiotic 
selection, dosing, or duration of therapy (8). Pay for perfor-
mance programs are intended to strengthen the business case 
for the improvement of antibiotic usage by rewarding excellence 
and reversing what have been described as perverse financial 
 incentives (9).
Nevertheless, initial ASP efforts were focused on adult patient 
populations. In 2010, the Pediatric Infectious Diseases Society 
(PIDS) formed the Pediatric Committee on Antimicrobial 
Stewardship with the mission of advancing pediatric ASPs, 
promoting research in pediatric ASPs, and developing ASPs 
educational programs. Since then, more concerted efforts for 
the widespread implementation of formal ASPs in pediatrics 
have occurred (10). Although promising, current evidences are 
limited to outpatient services (11) and in high-income countries 
(12). Thus, concluding that present pediatric ASPs are generally 
effective in both inpatient and outpatient treatments and both 
resource-rich and resource-limited settings could be subjected to 
multiple biases.
Implementation of ASPs to prevent and to control the emer-
gence and spread of antimicrobial-resistant microorganisms 
is one of the key elements in quality improvement required by 
the Joint Commission International (JCI). Rational antibacterial 
use was listed as one of the important patient safety goals in 
Guangzhou Women and Children’s Medical Center (GWCMC) 
in 2011–2012, and GWCMC successfully passed the JCI 
accreditation on December 15, 2012. During the journey to JCI 
accreditation, GWCMC performed two different hospital-wide 
stewardship interventions in succession: prior authorization 
alone and prior authorization + financially punished audit and 
feedback. The aim of this study was to determine the incremental 
effect of financially punished audit and feedback, to discuss the 
effectiveness of such cheap and simple stewardship interventions 
in the pediatric context, and to provide references for community 
hospitals and international counterparts.
MaTerials anD MeThODs
setting and Design
An uncontrolled, observational study focusing on hospital-wide 
antibacterial use was performed in GWCMC, a 1012-bed tertiary 
pediatric hospital with 2.65 million outpatient visits, 45,000 
Medicare inpatient admissions, and 313,785 inpatient days 
annually in Guangzhou, China. Approval was obtained from the 
GWCMC Institutional Review Board.
This was a three-stage study (Figure  1A). The first stage 
without formalized ASPs served as pre-intervention period and 
was started from January 1, 2011 to April 30, 2011. In the second 
stage or the first-intervention period, a formulary restriction with 
prior authorization according to the campaign protocol launched 
by the Chinese Ministry of Health in 2011 was implemented 
between May 1, 2011 and September 30, 2011 (13). In the third 
stage or the second-intervention period, financially punished 
audit and feedback was added to the prior authorization since 
October 1, 2011.
results: Before the second-intervention period, neither the proportion of antibiotic 
prescriptions nor the proportion of expenditure on antibiotics declined significantly in 
both ambulatory and inpatient settings. However, after the introduction of financially pun-
ished audit and feedback, the proportion of both antibiotic prescriptions (β = −6.269, 
P < 0.001, and reduction = 59.4% for outpatients; β = −1.235, P < 0.001, and reduc-
tion = 19.8% for inpatients) and expenditure on antibiotics (β = −7.777, P < 0.001, and 
reduction = 46.7% for outpatients; β = −4.933, P = 0.001, and reduction = 16.3% for 
inpatients) dropped immediately.
conclusion: The combination of more than one core strategies (prior authorization, 
audit and feedback, and pay for performance) will be more effective than one strategy 
alone.
Keywords: prior authorization, audit and feedback, pay for performance, antimicrobial prescription, antimicrobial 
stewardship, observational study
FigUre 1 | Timeline of antimicrobial stewardship program (asP) strategies (a) and flowchart for the intervention of financially punished audit and 
feedback (B).
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antimicrobial stewardship Programs
Establishment of Core Team
Prior to implementation of the programs, a multidisciplinary 
ASPs committee, including administrating group, supervision 
group, and implementation group, was established (Figure S1 in 
Supplementary Material). Administrating group composed of 
hospital administrators is responsible for providing support to 
hospital administration and medical staff leadership. Supervision 
group by pharmacists, a board certified pediatric infectious disease 
practitioner, information systems experts, and microbiologists 
bear the main responsibility of the enforcement of antimicrobial 
restriction policies. The mission of the implementation group by 
physicians is to fully implement the guidelines.
With reference to the first national guideline on the clinical 
use of antibacterial medicines published in 2004 (14) and the 
official document for rational use and standard management of 
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antibiotics issued by Chinese Ministry of Health in 2011 (15), 
the ASP team developed antimicrobial guidelines for pediatric 
patients, including choice of antibiotic agent, accuracy of the 
dose, appropriateness of the route, period of use, and need for 
combination of antibiotics, and made it available as part of the 
hospital formulary. The guidelines were made available in written 
pocket-sized formats and were easily accessible through the hos-
pital Intranet 1 month before starting the ASP. We also developed 
a set of simple and economical tailor-made indications for the 
prescription of rational antibiotics (Table S1 in Supplementary 
Material).
Prior Authorization
Antibiotics used in the center were divided into non-restricted 
(also called “first line”), restricted (“second line”), and special 
use (“third line”) grades on the basis of their clinical effects and 
safety. The antibacterial formulary was shown in Table S2 in 
Supplementary Material. Each grade will match exactly to the 
corresponding prescribing privileges for physicians, as described 
previously (16). Briefly, physicians do not need prior approval 
to prescribe unrestricted antibiotics; senior physicians were 
allowed to prescribe restricted antibiotics, but access to these 
antibiotics was strictly controlled for the junior residents and fel-
lows; and all physicians need the special-grade antibiotic expert 
subcommittee’s approval before they can prescribe special-grade 
antibiotics.
The antibiotic approval service was staffed by clinical pharma-
cists and infection control physicians between 8:00 a.m. and 5:00 
p.m. on weekdays and by the first- and second-year pharmacist 
and infection diseases fellows with postgraduate training in anti-
infective therapy between 5:00 p.m. and 12:00 p.m. on weekdays 
and between 8:00 a.m. and 12:00 p.m. on weekends and holidays. 
Between 00:00 a.m. and 8:00 a.m., restricted and special-grade 
agents were released pending morning evaluation to prevent 
delay in appropriate treatment. Of course, if a request was denied, 
an alternative agent would be suggested.
Financially Punished Audit and Feedback
Prospective Audit and Feedback
To better utilize the ASP resources, prospective audit with feed-
back was also introduced in October 2011. In the audit process, 
an automated report of all patients who had received antimicro-
bials within the previous 24 h was generated daily from a web-
based prescription screening software, except on weekends and 
holidays. Prospective audits of antimicrobials prescribed during 
the weekend and holidays were performed on Mondays and the 
first day after holidays. Critical data elements extracted from the 
system included type of antimicrobial; dose, interval, and route of 
administration; patient age, weight, allergies, and renal function; 
attending physician and admitting service names; and culture 
results of microbiology for hospitalized patients from any site. 
The supervision group was responsible for reviewing all of these 
reports and judging the appropriateness of the use of antibiotics. 
Subjects were excluded if antibiotic approval had already been 
authorized by clinical pharmacists and infection control physi-
cians before the call.
Common feedback was performed through direct commu-
nication with the attending physician who prescribed the anti-
biotics, including discontinue the antibiotic; narrow or broaden 
antimicrobial therapy based on culture and susceptibility data; 
convert the administration method from parenteral to oral 
route; increase or decrease the dose; and shorten or lengthen the 
planned duration of therapy, consolidate to fewer antimicrobi-
als, and obtain an infectious diseases consult. At the end of each 
month, the data on irrational use of antibiotics were collected and 
reported to the administrating group by the supervision group. 
Appropriate evaluation of antibacterial-containing prescriptions 
was published monthly by the administrating group on the 
 hospital local area network. Figure 1B depicts the workflow of 
the audit and feedback intervention.
Financial Penalties
“Dear doctor” letters were sent from the ASPs team to physicians. 
Physicians were given the opportunity to present evidence and 
argument against the results of feedback during a 7-day public 
notice period. Subsequently, physicians who wrote inappropriate 
prescriptions would face a hefty fine according to the number of the 
inappropriate prescriptions (first quartile, second quartile, third 
quartile, and fourth quartile). The level of fine was correspond-
ingly divided into four levels [first – 500 Chinese Yuan (CNY); 
second – 700 CNY; third – 900 CNY; and fourth – 1000 CNY]. If 
a second instance of a fourth-grade error occurs, the responsible 
physician would face the prescribing privilege revocation and be 
asked to attend mandatory training on antibiotic use again.
Measures of antimicrobial Use
The total number of prescriptions and total number of prescrip-
tions containing antibacterial were derived from the prescription 
evaluation software embedded in the Hospital Information 
System (HIS). Data elements for each antibiotic prescriptions 
include the patients’ demographics (e.g., patient name, identifica-
tion number, age, diagnosis, allergy history, body weight, body 
surface area, and clinical laboratory test results), antibiotic usage 
(generic names, doses, dosing schedules, timing, duration, com-
binations, and any switchovers to another antibiotic), and cost 
(antibacterial expenditure and cost of all medications).
Outcome Measures
The outcome measures included proportion of pediatric antibi-
otic prescriptions, proportion of prescriptions containing non-
restricted antibacterial, proportion of prescriptions containing 
restricted antibacterial, proportion of prescriptions containing 
special use grade antibacterial, percentage of monthly antibiotic 
users of hospitalized children, and proportion of expenditure on 
antibacterial relative to all medications. Outpatient and inpatient 
wards were calculated, respectively.
statistical analysis
We determined the differences in the average monthly changes 
in antibiotic use before and after the ASPs program by using 
interrupted time series via dynamic regression (17). Given the 
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presence of three distinct stages, a model with two change points 
was used:
 
Y F
F S S
t 0 1 t 2 t 3
4 t 5
time
× time after time after 
= β +β × +β × +β
+β × +β ×  
Here, Yt is the mean of the indicators used to evaluate antimi-
crobial use prescription; timet is the number of months at time t 
from the beginning of the study; “F” and “S” are the indicators 
for time t that the “first-intervention (F)” was introduced in May 
(before May = 0 and after May = 1) and the “second-intervention 
(S)” was introduced in October (before October =  0 and after 
October = 1). Time after “F” and “S” are the number of months after 
the first-intervention in May and after the second-intervention in 
October. In this model, β0 estimates the intercept, β1 evaluated the 
baseline trend during pre-intervention period, β2 and β4 estimate 
the immediate changes following the first-intervention in May 
2011 and the second-intervention in October 2011, β3 assesses 
the change trends of the outcome of interest after the “first-
intervention” and before the second-intervention. β5 estimates 
the change trends of the outcome of interest after the second-
intervention. In the autoregression model, serial correlation of the 
error terms was tested by plot of residuals against time and using 
the Durbin–Watson test. Randomly scattered residuals without a 
pattern indicate that there is no autocorrelation. Durbin–Watson 
statistic values close to 2.0 indicate no serious autocorrelation. If 
the statistic is significant, the models were adjusted by estimat-
ing the autocorrelation parameter and including autocorrelated 
errors by following a second-order autoregressive process. The 
percentage of changes by the “Second-intervention” was calcu-
lated by the formula as follow:
 
β
β β β β
4
0 1 2 3
100
+ + +
× %.
 
In addition, chi-square test was used for testing the percentage 
differences between two or more groups. We used P < 0.05 as a 
threshold for statistical significance. All statistical analyses and 
models were estimated by using SAS 8.1 software (SAS Institute, 
Cary, NC, USA).
resUlTs
In total, 29,363,808 medical prescriptions were included in 
this study; 3,036,274 prescriptions (1,532,336 for outpatients 
and 1,503,938 for inpatients) were in the pre-intervention 
period, 4,573,601 prescriptions (2,450,093 for outpatients and 
2,123,509 for inpatients) were in the first-intervention period, 
and 21,753,933 prescriptions (15,499,762 for outpatients and 
6,254,171 for inpatients) were in the second-intervention period.
general information and 
Pharmacoeconomic Data on 
antibacterial Prescriptions
As shown in Table  1, compared to the pre-intervention stage, 
significant decreases in the rate of antibiotic prescription 
were observed both in the first-intervention period and in the 
second-intervention period for both outpatients (χ2 = 7.4 × 105, 
P <  0.001) and inpatients (χ2 =  2.0 ×  104, P <  0.001). During 
the pre-intervention period, the proportions of expenditure on 
antibiotics were approximately three times than that of second-
intervention period for outpatients (17 vs. 6%) and two times for 
inpatients (29 vs. 14%). The proportion of hospitalized children 
who took antibiotics decreased significantly from 40% in the 
pre-intervention group, to 34% after the implementation of prior 
authorization alone, and to 23% after adding financially punished 
audit and feedback (χ2 = 3.0 × 103, P < 0.001).
The top 10 antibiotics prescribed during three periods are 
shown in Table S3 in Supplementary Material. For outpatients, 
although there was a significant decrease in the rate of the No. 
1 antibiotic used, the highest rate of amoxicillin and clavulanic 
acid prescription was observed throughout three periods. In addi-
tion, during both the first-intervention period and the second- 
intervention period, new rankings of the top 10 antibiotics showed 
a significant decline in the third-generation cephalosporins, such 
as Cefixime (No. 4 in the pre-intervention, No. 8 after first-inter-
vention, and excluded from the top 10 after second-intervention). 
For inpatients, a significant drop was observed in the rankings of 
“Piperacillin and enzyme inhibitor” used (No. 1 → No. 3 → No. 8) 
after the implementation of interventions. Conversely, the rank-
ings of the second-generation cephalosporins increased obviously 
(Table S3 in Supplementary Material).
changes in the Proportion of antibiotic 
Prescriptions among Three 
Distinct Periods
Outpatient-Specific Analysis
As shown in Figure  2A, after the release of the ASPs in May 
2011, there is a notable decline in the monthly proportion of 
prescriptions containing antibiotics for outpatients, particularly 
since the implementation of the financially punished audit and 
feedback in September 2011. Statistically speaking, proportion 
of antibiotic prescriptions for outpatients dropped immediately 
after adding the financially punished audit and feedback to the 
prior authorization (coefficient: −6.269, P <  0.001, reduction: 
59.4%) (Table  2). No significant downtrends were identified 
within pre-intervention period (coefficient: −0.023, P = 0.947) 
and first-intervention period (coefficient: −0.200, P  =  0.392) 
(Table 2).
In an antibiotic grade-specific analysis, adding of the finan-
cially punished audit and feedback led to an immediately sharp 
decrease in the prescriptions of both non-restricted (P < 0.001) 
and restricted (P < 0.001) antibiotics for outpatients (Table 2). 
According to the class of antibiotics, stratified analyses showed 
that the prescriptions of penicillin (P = 0.001), cephalosporins 
(P  <  0.001), other beta-lactam (P  <  0.001), and macrolide 
(P < 0.001) for outpatients were immediately reduced to a much 
greater extent after adding financially punished audit and feed-
back than after the prior authorization alone (Table 2).
Inpatient-Specific Analysis
Figure 2A also illustrates the trends in monthly proportions of 
prescriptions containing antibiotics for inpatients from January, 
TaBle 1 | general information and pharmacoeconomic data on antibacterial prescriptions for outpatients and inpatients by three periods.
indicators Outpatients inpatients
Pre-
intervention
First- 
intervention
second-
intervention
Pre-
intervention
First- 
intervention
second-
intervention
Total number of prescriptions 1,532,336 2,450,093 15,499,762 1,503,938 2,123,509 6,254,171
Number and proportion of antibiotic 
prescriptions
196,139 (12.8) 264,610 (10.8) 325,495 (2.1) 97,756 (6.5) 121,040 (5.7) 256,421 (4.1)
Antimicrobials according to grade, N (%)
Non-restricted antimicrobials 137,046 (9.0) 185,648 (7.6) 230,066 (1.5) 36,966 (2.5) 47,694 (2.3) 98,965 (1.6)
Restricted antimicrobials 57,243 (3.8) 75,461 (3.1) 95,386 (0.6) 50,692 (3.4) 60,111 (2.8) 126,873 (2.0)
Special-grade antimicrobials 1838 (0.1) 3456 (0.1) 29 (0.0) 10,098 (0.7) 13,231 (0.6) 30,581 (0.5)
Antimicrobials according to class, N (%)
Penicillin 4932 (0.3) 8345 (0.3) 18,841 (0.1) 6983 (0.5) 8391 (0.4) 8825 (0.1)
Penicillin preparation 47,978 (3.1) 60,286 (2.5) 71,151 (0.6) 25,223 (1.7) 23,298 (1.1) 32,716 (0.5)
Cephalosporin 105,385 (7.0) 148,592 (6.1) 185,412 (1.2) 48,741 (3.3) 69,324 (3.3) 164,767 (2.7)
Other beta-lactam 1849 (0.1) 1776 (0.1) 7 (0.0) 2474 (0.2) 2238 (0.1) 0 (0.0)
Aminoglycoside 24 (0.0) 38 (0.0) 28 (0.0) 371 (0.0) 408 (0.0) 1300 (0.0)
Carbapenems 3 (0.0) 6 (0.0) 6 (0.0) 4584 (0.3) 7024 (0.3) 20,963 (0.3)
Glycopeptide 0 (0.0) 2 (0.0) 0 (0.0) 1277 (0.1) 1757 (0.1) 6279 (0.1)
Macrolide 34,390 (2.3) 42,405 (1.7) 44,852 (0.3) 5284 (0.4) 4942 (0.2) 13,715 (0.2)
Other antibiotics 1566 (0.2) 3115 (0.1) 5184 (0.0) 2819 (0.2) 3654 (0.2) 7854 (0.1)
Number of inpatients who took antibiotics (%) – – – 7562 (40.0) 9247 (33.9) 20,662 (22.9)
Total expenditure on antibacterial (Yuan) 8,759,640 12,228,653 17,946,806 9,127,932 11,075,074 21,135,351
Proportion of expenditure on antibacterial (%) 17.1 14.0 6.0 28.8 23.2 14.0
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2011 to December, 2012. Proportion of antibiotic prescrip-
tions for inpatients dropped significantly (coefficient: −1.235, 
P <  0.001, reduction: 19.8%), immediately after the introduc-
tion of financially punished audit and feedback (Table  3). 
Furthermore, there was no significant downtrends before the 
financially punished audit and feedback, including the single 
prior authorization intervention period (coefficient: −0.058, 
P = 0.667) (Table 3). The percentage of monthly antibiotic users 
of hospitalized children was also decreased (coefficient: −9.124, 
P <  0.001, reduction: 15.5%) immediately after the combina-
tion of financially punished audit and feedback. Although the 
subsequent percentage significantly increased during the 
second-intervention period, the magnitude (3.478 vs. −9.124) 
was much lower than that of the decrease resulted from the ASPs 
change (Table 3).
In subgroup analyses, implementation of the financially 
punished audit and feedback led to sharp decreases in all three 
grades of antibiotics in inpatients (all P  <  0.001) (Table  3). 
Further stratified analyses of antibiotic kinds demonstrated that 
combined ASPs could immediately reduce the prescriptions of 
penicillin (P =  0.001), cephalosporins (P =  0.004), other beta-
lactam (P < 0.001), and carbapenems (P < 0.001) and continue 
to play this role for carbapenems (P = 0.037) in the subsequent 
period (Table 3).
changes in the Proportion of expenditure 
on antibiotics relative to all Medications
As shown in Figure 2B, after the release of the financially pun-
ished audit and feedback in September, 2011, there is a notable 
decline in the proportions of expenditure on antibiotics relative to 
all medications in both outpatient and inpatient wards.
Outpatient-Specific Analysis
In the periods before financially punished audit and feedback 
implementation, even in the first-intervention period during 
which prior authorization had been started, there were no signifi-
cant downtrends of the proportions of expenditure on antibiotics 
relative to all medications (coefficient = 0.145 and P = 0.932 for 
pre-intervention period; coefficient = 0.555 and P = 0.390 for the 
first-intervention period). After the financially punished audit 
and feedback was implemented, the proportions of expenditure 
on antibiotics experienced an immediate decline (coefficient: 
−7.777, P < 0.001, reduction: 46.7%) (Table 2).
Inpatient-Specific Analysis
In the periods after the prior authorization alone and before the 
implementation of financially punished audit and feedback, the 
proportion of expenditure on antibiotics was slowly reduced 
(coefficient: −1.603, P =  0.013). However, after the financially 
punished audit and feedback was implemented, the proportion 
of expenditure on antibiotics immediately declined by 16.3% 
(coefficient: −4.933, P = 0.001) (Table 3). The equations should 
be inserted in editable format from the equation editor.
DiscUssiOn
Medically inappropriate, ineffective, and economically inefficient 
use of antibiotics is commonly observed in the health-care units 
throughout the countries of all income levels, especially in the 
developing countries (18). As China emerging as the largest 
developing country and the world’s largest producer and user of 
antibiotics (19), policy makers are under pressure to control inap-
propriate use of antibiotic without adversely affecting the quality 
FigUre 2 | Trends in the proportion of antibiotic prescriptions (a) and that of expenditure on antibiotics (B) by month in both ambulatory and 
inpatient settings.
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of care. Previous literature supports all three methods (prior 
authorization, audit and feedback, and pay for performance) 
as being effective strategies to decrease antimicrobial exposure, 
decrease costs, and improve clinical outcomes (20, 21). However, 
because these three ASP methods have not been compared or 
combined, the most effective approach remains unclear. This 
is the first study to evaluate whether combining three methods 
could result in more influences on antibiotic use in pediatrics 
than one method alone.
After release of the prior authorization alone in May 2011, 
hospital-wide overall antibiotic use slowly started to decrease. 
However, these changes were not statistically significant until 
the combination with financially punished audit and feedback 
in September 2011. Compared to patterns before combining, 
the proportions of prescriptions of the overall antibiotic use 
declined nearly 60 and 20% for outpatients and inpatients, 
respectively. Correspondingly, the proportion of expenditure on 
antibiotics relative to all medications decreased approximately 
47 and 16% for outpatients and inpatients, respectively. These 
findings suggest that financially punished audit and feedback is 
capable of catalyzing improvement in efforts on appropriate use 
of antibiotics in pediatric hospital that is already engaged in prior 
authorization.
Generally, our findings are in line with and build on the 
existing evidence based on the previous studies that examined 
the effect of pediatric ASPs. Hersh et  al. reported an average 
monthly decline in days of therapy/1000 patient days of 5.7% after 
implementing an ASP compared with control hospitals within the 
Pediatric Health Information System network (22). Di Pentima 
et al. reported a significant impact on reducing antimicrobial use 
after implementing an ASP, with the reductions of approximately 
21 and 50% in antibiotic doses administered per 1000 patient days 
of targeted and non-targeted antimicrobial, respectively (23). In 
another study, an ASP was associated with a $370,069 reduction 
in projected annual cost related to restricted antimicrobial use 
(24). Regrettably, direct comparisons with our study are not avail-
able because the metrics used in these studies were not consistent. 
But, all these findings suggest that formalized ASPs in children’s 
hospitals are effective for improving antibiotic prescribing.
However, our study did not observe a significant decrease in 
all antimicrobial use in both ambulatory and inpatient clinical 
settings after the implementation of prior authorization alone, 
TaBle 3 | changes in the monthly proportion of antibiotic use and expenditure on antibiotics in inpatient setting.
indicators β0 β1 P1 β2 P2 β3 P3 β4 P4 β5 P5 R2
All antibiotics 6.807 (0.399) −0.050 (0.193) 0.798 −0.461 (0.245) 0.078 −0.058 (0.132) 0.667 −1.235 (0.216) <0.001 0.089 (0.107) 0.413 0.977
Antibiotics according to grade
Non-restricted 2.580 (0.123) −0.026 (0.056) 0.652 −0.026 (0.130) 0.847 −0.025 (0.045) 0.582 −0.561 (0.091) <0.001 0.047 (0.032) 0.156 0.969
Restricted 3.529 (0.367) 0.038 (0.191) 0.843 −0.374 (0.145) 0.020 −0.055 (0.125) 0.667 −0.623 (0.115) <0.001 −0.001 (0.100) 0.994 0.975
Special-grade 0.670 (0.052) −0.034 (0.019) 0.095 0.077 (0.056) 0.184 0.001 (0.020) 0.950 −0.162 (0.030) <0.001 0.041 (0.011) 0.001 0.845
Antimicrobials according to class
Penicillin 0.470 (0.036) −0.030 (0.017) 0.104 0.027 (0.025) 0.304 −0.001 (0.013) 0.922 −0.093 (0.021) 0.001 0.019 (0.008) 0.030 0.988
Penicillin preparation 2.216 (0.156) 0.092 (0.076) 0.245 −0.051 (0.128) 0.696 −0.190 (0.054) 0.003 −0.151 (0.109) 0.187 0.070 (0.042) 0.113 0.976
Cephalosporin 2.842 (0.329) −0.129 (0.160) 0.432 −0.278 (0.249) 0.280 0.173 (0.110) 0.135 −0.876 (0.258) 0.004 −0.035 (0.092) 0.704 0.842
Other beta-lactam 0.177 (0.011) −0.032 (0.004) <0.001 0.092 (0.011) <0.001 −0.008 (0.004) 0.057 −0.036 (0.006) <0.001 0.040 (0.002) <0.001 0.982
Aminoglycoside 0.022 (0.006) −0.002 (0.003) 0.413 −0.004 (0.006) 0.531 0.001 (0.002) 0.577 0.001 (0.004) 0.805 0.001 (0.002) 0.433 0.200
Carbapenems 0.356 (0.044) 0.049 (0.017) 0.010 −0.025 (0.048) 0.607 −0.019 (0.017) 0.273 −0.131 (0.027) <0.001 −0.022 (0.009) 0.037 0.595
Glycopeptide 0.068 (0.022) −0.008 (0.010) 0.439 −0.008 (0.024) 0.737 0.007 (0.008) 0.402 −0.001 (0.017) 0.970 0.003 (0.006) 0.570 0.378
Macrolide 0.392 (0.027) −0.000 (0.012) 0.976 −0.063 (0.029) 0.044 −0.013 (0.010) 0.205 0.004 (0.021) 0.849 0.014 (0.007) 0.059 0.880
Other antibiotics 0.265 (0.036) 0.015 (0.018) 0.418 0.071 (0.041) 0.108 −0.029 (0.013) 0.047 −0.037 (0.028) 0.210 0.017 (0.010) 0.109 0.789
Inpatients taking antibiotics 59.428 (2.124) −2.898 (1.015) 0.012 2.916 (2.110) 0.186 −0.391 (0.763) 0.616 −9.124 (1.632) <0.001 3.478 (0.570) <0.001 0.982
Expenditure on antibiotics 33.670 (1.579) 1.080 (0.729) 0.158 −1.838 (1.574) 0.260 −1.603 (0.572) 0.013 −4.933 (1.126) 0.001 0.143 (0.397) 0.723 0.981
β0-intercept, β1-trend during pre-intervention, β2-immediately changes following the first-intervention, β3-trends during the first-intervention period, β4-immediately changes following the second-intervention, β5-trends during the second-
intervention period. Bold font-Statistically significant results (P < 0.05).
TaBle 2 | changes in the monthly proportion of antibiotic prescriptions and expenditure on antibiotics in ambulatory setting.
indicators β0 β1 P1 β2 P2 β3 P3 β4 P4 β5 P5 R2
All antibiotics 11.189 (0.708) −0.023 (0.343) 0.947 −0.418 (0.358) 0.259 −0.200 (0.227) 0.392 −6.269 (0.321) <0.001 0.313 (0.197) 0.132 0.994
Antibiotics according to 
grade
Non-restricted 6.929 (0.321) −0.376 (0.149) 0.023 −0.550 (0.323) 0.108 0.164 (0.111) 0.158 −4.127 (0.264) <0.001 0.280 (0.094) 0.001 0.992
Restricted 3.909 (0.427) 0.111 (0.203) 0.594 0.023 (0.331) 0.946 −0.242 (0.144) 0.112 −1.357 (0.240) <0.001 0.130 (0.115) 0.275 0.967
Special-grade 0.091 (0.030) −0.044 (0.013) 0.004 0.132 (0.032) 0.001 0.003 (0.011) 0.792 −0.031 (0.023) 0.185 0.041 (0.008) <0.001 0.885
Antimicrobials according 
to classa
Penicillin 0.121 (0.060) −0.056 (0.027) 0.056 −0.017 (0.032) 0.601 0.052 (0.018) 0.010 −0.118 (0.029) 0.001 0.004 (0.017) 0.823 0.860
Penicillin preparation 3.117 (0.174) −0.181 (0.061) 0.009 −1.266 (0.132) <0.001 0.095 (0.049) 0.070 −0.051 (0.192) 0.793 0.096 (0.078) 0.237 0.987
Cephalosporin 5.862 (0.456) −0.021 (0.218) 0.926 −0.101 (0.251) 0.693 −0.069 (0.144) 0.639 −3.518 (0.243) <0.001 0.135 (0.128) 0.308 0.990
Other beta-lactam 0.193 (0.008) 0.014 (0.002) <0.001 0.045 (0.009) <0.001 0.020 (0.003) <0.001 −0.034 (0.003) <0.001 −0.035 (0.006) <0.001 0.645
Macrolide 1.513 (0.046) −0.231 (0.017) <0.001 −0.253 (0.049) <0.001 0.122 (0.017) <0.001 −0.889 (0.026) <0.001 0.128 (0.009) <0.001 0.996
Other antibiotics 0.198 (0.015) −0.041 (0.005) <0.001 −0.065 (0.012) <0.001 −0.001 (0.004) 0.392 0.070 (0.015) <0.001 0.043 (0.007) <0.001 0.871
Expenditure on antibiotics 18.784 (1.878) 0.145 (0.932) 0.878 −1.703 (1.178) 0.168 −0.555 (0.628) 0.390 −7.777 (0.996) <0.001 0.480 (0.498) 0.349 0.977
β0-intercept, β1-trend during pre-intervention, β2-immediately changes following the first-intervention, β3-trends during the first-intervention period, β4-immediately changes following the second-intervention, β5-trends during the second-
intervention period.
aThe proportions of aminoglycoside and carbapenems were excluded from analysis due to too small. Bold font-Statistically significant results (P < 0.05).
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based on the recommendation made by the “Clinical Application 
of Antibiotics Special Rectification Activities in 2011.” Although 
other explanations may limit the interpretation of this finding, 
our results implicated that the national special rectification 
activity without an effective antimicrobials stewardship cannot 
efficiently decrease the inappropriate and indiscriminate use of 
antibiotics. It may potentially be able to explain a given observed 
phenomenon that antibiotic use still remains at a higher level, 
and antibiotic resistance remains a challenge in China, despite 
sets of guidelines and regulations had been released during the 
past decade (25).
Understanding of which specific stewardship strategy is 
the most effective one, especially the intervention requiring 
lower levels of financial support, is particularly important (26). 
Unfortunately, so far, there is a lack of conclusive studies to draw 
definite conclusions of efficacy of different ASP interventions. As 
one of the most widely advocated strategies, little is known about 
the effect of prospective audit and feedback on reducing antibiotic 
prescribing in children’s hospital. In one well-documented case, 
compared with the antibiotic use of the control group, a monthly 
decline in all antibiotics of 7% (P = 0.05) and 8% (P = 0.05) was 
observed for days of therapy and length of therapy per 1000 
patient days, respectively (27). Hospitals with audit and feedback 
ASPs did reduce antibiotic use to a greater degree than those 
without. However, this was not universal. For example, accord-
ing to a study run by Mehta et al. (8), after the introduction of 
prospective audit with feedback, both total antimicrobial use 
(P < 0.001) and broad-spectrum anti-Gram-negative antimicro-
bial use (P < 0.001) increased significantly.
As another widely advocated strategy, even less is known 
about the effects of financial incentives/penalties for prescribers. 
According to the latest available updates of a systematic review in 
2015 (28), (i) pharmaceutical budgets may lead to a modest reduc-
tion in drug use (median relative change −2.8%; low-certainty 
evidence); (ii) effects of pay for performance policies on drug use 
and health outcomes are uncertain, and effects on drug costs and 
health-care utilization have not been measured; (iii) effects of 
the reimbursement rate reduction policy on drug use and drug 
costs are uncertain, and no included study assessed the effects 
of this policy on health-care utilization or health outcomes; and 
(iv) effects of financially punished policy were not reported at all.
Although both favorable clinical and economic outcomes 
were observed in the post-intervention phase, several limitations 
associated with this study should be acknowledged. First, process 
measures, such as the proportion of antibiotic prescriptions and 
expenditure on antibiotics, are considered inadequate to evaluate 
ASP interventions, because such outcomes do not demonstrate 
direct clinical benefits (29). For example, one important focus of 
ASPs is to guide clinicians from broader- to narrower-spectrum 
antibiotics. However, switch from one agent to another for de-
escalation would not be demonstrated by the proportion of anti-
biotic prescriptions and expenditure metrics. Additionally, many 
other important outcomes related to ASPs, including changes in 
days of therapy per 1000 patient days, rates of multidrug-resistant 
organisms and Clostridium difficile infection, conservable days of 
therapy, and unplanned hospital readmission within 30 days after 
discharge from the hospital, were not measured in this study (30).
Second, this study is in essence a description of what hap-
pened in a pediatric hospital after introducing ASPs. It is just 
an uncontrolled, observational study without simultaneous 
control group. Thus, we should note all the limitations of obser-
vational studies, and this study design does not permit clear 
determination of causation in the changes observed. Third, 
patient adherence to treatment regimens was not monitored, 
so that prescribing data may not accurately represent actual 
antibacterial use, particularly for outpatients (31). Fourth, the 
influence of factors other than the change in ASP cannot be 
fully excluded. For instance, the decreased use of certain types 
of antibiotics before the intervention suggests that external 
factors, such as seasonal variation that January is a peak season 
of some pediatric infectious diseases (32), may have lead to 
a downtrend. Fifth, time duration is likely too short to avoid 
an additive effect. For example, interventions in the hospital 
level take time to “diffuse” through and 3 months of the first-
intervention period is too short to be able to tease out the 
individual effects of each intervention introduced. To increase 
the validity of the results, future research should include several 
years of data before and, ideally, after implementation of similar 
ordinances and should use statistical methods that control 
for secular trends and random effects. Finally, the success of 
interventions depends on the specific prescribing behaviors and 
specific barriers to behavior change in each setting. Thus, the 
generalizability of our findings to non-freestanding children’s 
hospitals is uncertain.
In conclusion, even with all the limitations of any observational 
study, this study observed a significant decline in antibiotic use 
and corresponding expenditure in both ambulatory and inpatient 
clinical settings after the inclusion of financially punished audit 
and feedback to an ASP based on prior authorization alone. This 
implies that the combination of more than one core strategies 
(prior authorization, audit and feedback, and pay for perfor-
mance) will be more effective than one strategy alone. We are 
initiating another research project to determine whether financial 
incentives or the restructuring of payment models can stimulate 
more meaningful improvements.
aUThOr cOnTriBUTiOns
Study concept and design: SG, HL, and HY; analysis and inter-
pretation of data: XQ, SS, YL, and HL; acquisition of data: YS, 
XS, ML, RL, and QW; drafting of the manuscript: SG, HX, and 
HY; administrative, technical, and material support: YH, YC, LH, 
LZ, WZ, JM, LL, and YX; critical revision of the manuscript for 
important intellectual content: HX, SG, and HL; and all authors 
critically read the manuscript, revised it, and approved the final 
version.
acKnOWleDgMenTs
The authors are grateful to all those who contributed to the pro-
ject implementation, including researchers, project coordinators, 
clinical doctors, and data clerks. The authors are also thankful 
to Prof. Getu Zhaori, Charles P. Larson, and Keqin Rao for their 
support in the manuscript preparing.
10
Gong et al. Improvement of Antibiotic Stewardship Program
Frontiers in Public Health | www.frontiersin.org May 2016 | Volume 4 | Article 99
FUnDing
This work was supported by the Guangzhou Science and 
Technology Bureau, Guangzhou, China (201041-E00741 and 
2012J5100038).
sUPPleMenTarY MaTerial
The Supplementary Material for this article can be found 
online at http://journal.frontiersin.org/article/10.3389/fpubh. 
2016.00099
reFerences
1. Planta MB. The role of poverty in antimicrobial resistance. J Am Board Fam 
Med (2007) 20:533–9. doi:10.3122/jabfm.2007.06.070019 
2. Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, 
et  al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis 
(2013) 13:1057–98. doi:10.1016/s1473-3099(13)70318-9 
3. Macao P, Lopes JC, Oliveira H, Oliveira G, Rodrigues F. Health care associated 
multidrug-resistant bacteria in a pediatric hospital: five year experience. Acta 
Med Port (2013) 26:385–91. 
4. Elliott SP. Antimicrobial-resistant pathogens: an emerging pediatric threat. 
Adv Pediatr (2008) 55:329–48. doi:10.1016/j.yapd.2008.07.004 
5. Canton R, Horcajada JP, Oliver A, Garbajosa PR, Vila J. Inappropriate use 
of antibiotics in hospitals: the complex relationship between antibiotic use 
and antimicrobial resistance. Enferm Infecc Microbiol Clin (2013) 31(Suppl 
4):3–11. doi:10.1016/s0213-005x(13)70126-5 
6. Gerber JS, Newland JG, Coffin SE, Hall M, Thurm C, Prasad PA, et al. Variability 
in antibiotic use at children’s hospitals. Pediatrics (2010) 126:1067–73. 
doi:10.1542/peds.2010-1275 
7. Nicolle LE. Antimicrobial stewardship in long term care facilities: what is effec-
tive? Antimicrob Resist Infect Control (2014) 3:6. doi:10.1186/2047-2994-3-6 
8. Mehta JM, Haynes K, Wileyto EP, Gerber JS, Timko DR, Morgan SC, et al. 
Comparison of prior authorization and prospective audit with feedback for 
antimicrobial stewardship. Infect Control Hosp Epidemiol (2014) 35:1092–9. 
doi:10.1086/677624 
9. Lindenauer PK, Remus D, Roman S, Rothberg MB, Benjamin EM, Ma A, et al. 
Public reporting and pay for performance in hospital quality improvement. N 
Engl J Med (2007) 356:486–96. doi:10.1056/NEJMsa064964 
10. Hyun DY, Hersh AL, Namtu K, Palazzi DL, Maples HD, Newland JG, et al. 
Antimicrobial stewardship in pediatrics: how every pediatrician can be a stew-
ard. JAMA Pediatr (2013) 167:859–66. doi:10.1001/jamapediatrics.2013.2241 
11. Gerber JS, Prasad PA, Fiks AG, Localio AR, Grundmeier RW, Bell LM, et al. 
Effect of an outpatient antimicrobial stewardship intervention on broad- 
spectrum antibiotic prescribing by primary care pediatricians: a randomized 
trial. JAMA (2013) 309:2345–52. doi:10.1001/jama.2013.6287 
12. Le Doare K, Barker CI, Irwin A, Sharland M. Improving antibiotic prescrib-
ing for children in the resource-poor setting. Br J Clin Pharmacol (2015) 
79:446–55. doi:10.1111/bcp.12320 
13. Xiao Y, Zhang J, Zheng B, Zhao L, Li S, Li L. Changes in Chinese policies 
to promote the rational use of antibiotics. PLoS Med (2013) 10:e1001556. 
doi:10.1371/journal.pmed.1001556 
14. National Health and Family Planning Commission of the People’s Republic 
of China. (2004). Guidelines to Use of Antibiotics in Clinic. Beijing: People’s 
Medical Publishing House.
15. National Health and Family Planning Commission of the People’s Republic of 
China. (2011). Notice Regarding National Special Measure Scheme on Clinical 
Use of Antibiotics in 2011. Beijing: People’s Medical Publishing House.
16. Song P, Li W, Zhou Q. An outpatient antibacterial stewardship intervention 
during the journey to JCI accreditation. BMC Pharmacol Toxicol (2014) 15:8. 
doi:10.1186/2050-6511-15-8 
17. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression 
analysis of interrupted time series studies in medication use research. J Clin 
Pharm Ther (2002) 27:299–309. doi:10.1046/j.1365-2710.2002.00430.x 
18. Huttner A, Harbarth S, Carlet J, Cosgrove S, Goossens H, Holmes A, et al. 
Antimicrobial resistance: a global view from the 2013 World Healthcare-
Associated Infections Forum. Antimicrob Resist Infect Control (2013) 2:31. 
doi:10.1186/2047-2994-2-31 
19. Yezli S, Li H. Antibiotic resistance amongst healthcare-associated patho-
gens in China. Int J Antimicrob Agents (2012) 40:389–97. doi:10.1016/j.
ijantimicag.2012.07.009 
20. Yeo CL, Chan DS, Earnest A, Wu TS, Yeoh SF, Lim R, et al. Prospective audit 
and feedback on antibiotic prescription in an adult hematology-oncology unit 
in Singapore. Eur J Clin Microbiol Infect Dis (2012) 31:583–90. doi:10.1007/
s10096-011-1351-6 
21. Yip W, Powell-Jackson T, Chen W, Hu M, Fe E, Hu M, et  al. Capitation 
combined with pay-for-performance improves antibiotic prescribing prac-
tices in rural China. Health Aff (Millwood) (2014) 33:502–10. doi:10.1377/
hlthaff.2013.0702 
22. Hersh AL, De Lurgio SA, Thurm C, Lee BR, Weissman SJ, Courter JD, et al. 
Antimicrobial stewardship programs in freestanding children’s hospitals. 
Pediatrics (2015) 135:33–9. doi:10.1542/peds.2014-2579 
23. Di Pentima MC, Chan S, Hossain J. Benefits of a pediatric antimicrobial 
stewardship program at a children’s hospital. Pediatrics (2011) 128:1062–70. 
doi:10.1542/peds.2010-3589 
24. Agwu AL, Lee CK, Jain SK, Murray KL, Topolski J, Miller RE, et  al. A 
World Wide Web-based antimicrobial stewardship program improves 
efficiency, communication, and user satisfaction and reduces cost in a 
tertiary care pediatric medical center. Clin Infect Dis (2008) 47:747–53. 
doi:10.1086/591133 
25. Li Y. China’s misuse of antibiotics should be curbed. BMJ (2014) 348:g1083. 
doi:10.1136/bmj.g1083 
26. Johannsson B, Beekmann SE, Srinivasan A, Hersh AL, Laxminarayan 
R, Polgreen PM. Improving antimicrobial stewardship: the evolution of 
programmatic strategies and barriers. Infect Control Hosp Epidemiol (2011) 
32:367–74. doi:10.1086/658946 
27. Newland J, Stach L, De Lurgio S, Hedican E, Yu D, Herigon J, et al. Impact 
of a prospective audit with feedback antimicrobial stewardship program at 
a children’s hospital. J Pediatric Infect Dis Soc (2012) 1:179–86. doi:10.1093/
jpids/pis054 
28. Rashidian A, Omidvari AH, Vali Y, Sturm H, Oxman AD. Pharmaceutical 
policies: effects of financial incentives for prescribers. Cochrane Database Syst 
Rev (2015) 8:Cd006731. doi:10.1002/14651858 
29. McGowan JE. Antimicrobial stewardship – the state of the art in 2011: focus 
on outcome and methods. Infect Control Hosp Epidemiol (2012) 33:331–7. 
doi:10.1086/664755 
30. Morris AM, Brener S, Dresser L, Daneman N, Dellit TH, Avdic E, et al. Use 
of a structured panel process to define quality metrics for antimicrobial 
stewardship programs. Infect Control Hosp Epidemiol (2012) 33:500–6. 
doi:10.1086/665324 
31. Gerber JS, Kronman MP, Ross RK, Hersh AL, Newland JG, Metjian 
TA, et  al. Identifying targets for antimicrobial stewardship in chil-
dren’s hospitals. Infect Control Hosp Epidemiol (2013) 34:1252–8. 
doi:10.1086/673982 
32. Ambrosioni J, Bridevaux PO, Wagner G, Mamin A, Kaiser L. Epidemiology 
of viral respiratory infections in a tertiary care centre in the era of molecular 
diagnosis, Geneva, Switzerland, 2011-2012. Clin Microbiol Infect (2014) 
20:578–84. doi:10.1111/1469-0691.12525 
Conflict of Interest Statement: The research was conducted in the absence of any 
commercial or financial relationships that could be construed as a potential conflict 
of interest.
Copyright © 2016 Gong, Qiu, Song, Sun, He, Chen, Li, Luo, He, Wei, Shen, 
Liu, Zhang, Zhou, Huang, Mai, Liu, Xu, Liang and Xia. This is an open-access 
article distributed under the terms of the Creative Commons Attribution License 
(CC BY). The use, distribution or reproduction in other forums is permitted, 
provided the original author(s) or licensor are credited and that the original 
publication in this journal is cited, in accordance with accepted academic prac-
tice. No use, distribution or reproduction is permitted which does not comply 
with these terms.
